Fibrinogen receptor antagonists for inhibiting aggregation of blood
申请人:Merck & Co., Inc.
公开号:US05455243A1
公开(公告)日:1995-10-03
Fibrinogen receptor antagonists of the formula: ##STR1## such as ##STR2## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.